Combination of the NRF2 Inhibitor and Autophagy Inhibitor Significantly Inhibited Tumorigenicity of Castration-Resistant Prostate Cancer

<div>Bioinformatics analysis of NRF2 in prostate cancer. (a) The differently expressed genes between NRF2-high and NRF2-low groups were identified. (b, c) KEGG analysis of upregulated and downregulated DEGs in PCa.</div>

Computational and Mathematical Methods in Medicine

fig6

Figure 6

Figure 6: Combination of the NRF2 Inhibitor and Autophagy Inhibitor Significantly Inhibited Tumorigenicity of Castration-Resistant Prostate Cancer 